JANUX THERAPEUTICS INC's ticker is JANX and the CUSIP is 47103J105. A total of 59 filers reported holding JANUX THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206,196 | -6.0% | 20,456 | +10.7% | 0.00% | – |
| Q2 2023 | $219,368 | -45.9% | 18,481 | -44.8% | 0.00% | – |
| Q1 2023 | $405,399 | +76.1% | 33,504 | +91.6% | 0.00% | – |
| Q4 2022 | $230,264 | -88.0% | 17,484 | -87.6% | 0.00% | – |
| Q3 2022 | $1,916,000 | +468.5% | 141,480 | +410.2% | 0.00% | – |
| Q2 2022 | $337,000 | -15.3% | 27,733 | -0.0% | 0.00% | – |
| Q1 2022 | $398,000 | +39.6% | 27,743 | +91.6% | 0.00% | – |
| Q4 2021 | $285,000 | +96.6% | 14,479 | +116.0% | 0.00% | – |
| Q3 2021 | $145,000 | +7150.0% | 6,702 | +6602.0% | 0.00% | – |
| Q2 2021 | $2,000 | – | 100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 9,165,652 | $92,389,772 | 1.82% |
| BVF INC/IL | 4,579,818 | $46,164,565 | 1.24% |
| Samsara BioCapital, LLC | 360,414 | $3,632,973 | 1.11% |
| Orbimed Advisors | 3,317,927 | $33,444,704 | 0.71% |
| Old Well Partners, LLC | 10,300 | $103,824 | 0.09% |
| Corton Capital Inc. | 11,061 | $111,495 | 0.06% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 1,150,000 | $11,592,000 | 0.03% |
| XTX Topco Ltd | 13,636 | $137,451 | 0.02% |
| JANUS HENDERSON GROUP PLC | 2,067,468 | $20,823,593 | 0.01% |
| Alyeska Investment Group, L.P. | 175,000 | $1,764,000 | 0.01% |